Fumaric Acid

Fumaric Acid

SCHEMBL4270106

C=C(CC)C(=O)O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
TP53 P04637 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45
EGLN3 Q9H6Z9 1/20 0.45
HCAR2 Q8TDS4 6/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TET2 Q6N021 3/20 0.37
FFAR3 O14843 1/20 0.36
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7520083 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL7518651 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2213373 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL7518661 1.00 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
Crotonic Acid SCHEMBL27711584 0.89 ALOX15 (0.39) TSHRTP53EGLN1EGLN3HCAR2
Crotonic Acid SCHEMBL28123858 0.87 ALOX15 (0.38) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL4891196 0.87 ALOX15 (0.38) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL17865 0.87
SCHEMBL156659 0.87 FFAR3 (0.47) TSHRTP53ALOX15HSD17B10TET2
Acrylic Acid SCHEMBL28411354 0.85 ALOX15 (0.60) TSHRTP53ALOX15HSD17B10TET2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233935-A1 Methods for Fabrication of Antimicrobial Surfaces RESEARCH FOUNDATION OF CITY UNIVERSITY OF NEW YORK (US) 2009-09-17 US disclosed
EP-1945229-A2 METHODS FOR FABRICATION OF ANTIMICROBIAL SURFACES Research Foundation of the City University of New York (US) 2008-07-23 EP disclosed
WO-2008018890-A2 METHODS FOR FABRICATION OF ANTIMICROBIAL SURFACES RESEARCH FOUNDATION OF CITY UNIVERSITY OF NEW YORK (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233935-A1 Methods for Fabrication of Antimicrobial Surfaces ADH1A, ADH1C, HAO2 TSHR 2444/4885TP53 4117/4885EGLN1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.